Europe Approves Empagliflozin for Chronic Kidney Disease ...Middle East

Medscape - News
The SGLT2 inhibitor empagliflozin (Jardiance) was approved by European regulators for treating adults with chronic kidney disease. The FDA is reviewing a new drug application for this indication. Medscape Medical News

Hence then, the article about europe approves empagliflozin for chronic kidney disease was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Europe Approves Empagliflozin for Chronic Kidney Disease )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News